AI model can predict chemotherapy benefit in breast cancer

Deciding whether to administer chemotherapy after surgery is one of the most challenging questions in early-stage breast cancer care. While chemotherapy can reduce the risk of recurrence, most patients do not benefit from it and may experience significant short- and long-term side effects. The central challenge is identifying, at the time of diagnosis, which patients are likely to benefit and which are not.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup